Biotechnology developer Magenta Therapeutics, which exploits Harvard research, has launched with series A funding provided by investors including Alphabet.

PNC and First Data joined existing investor Intel Capital in a $31.5m round that increased the medical software provider's overall financing to more than $130m.

The Illumina-backed health supplement subcription service will use the capital to boost hiring and develop customised engagement programs for its subscribers.

Sarnoff spinout Intuity Medical has received cash from a range of existing and new venture capital investors to boost its total funding to nearly $200m.